☆ 4.8 Article

Analysis of neutralizing antibodies to COVID-19 inactivated or subunit recombinant vaccines in hospitalized patients with liver dysfunction

FRONTIERS IN IMMUNOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Gastroenterology & Hepatology

Safety and antibody response to inactivated COVID-19 vaccine in patients with chronic hepatitis B virus infection

Taiyu He et al.

Summary: This study investigated the safety and antibody responses of COVID-19 vaccination in patients with chronic hepatitis B (CHB) virus infection. The results showed that the vaccine was well tolerated and induced effective antibody responses in CHB patients.

LIVER INTERNATIONAL (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study

Jitao Wang et al.

Summary: This study examined the safety and immunogenicity of COVID-19 vaccination in patients with compensated and decompensated cirrhosis. The results showed that the vaccine was well tolerated with mostly mild and transient adverse events. Patients with Child-Pugh score of B and C levels had a weaker immune response to the vaccine.

HEPATOLOGY INTERNATIONAL (2022)

添加到收藏夹

Review Medicine, General & Internal

Coronavirus Disease 2019 Vaccinations in Patients With Chronic Liver Disease and Liver Transplant Recipients: An Update

Pimsiri Sripongpun et al.

Summary: COVID-19 poses a higher risk for patients with chronic liver disease and liver transplant recipients. Many liver societies recommend COVID-19 vaccinations for these patients, although there are limited studies on the risks and benefits in this population. Multiple doses of vaccines may be needed to provide sufficient immune response, especially for liver transplant recipients.

FRONTIERS IN MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021

Molly K. Steele et al.

Summary: This study estimated the number of SARS-CoV-2 infections and COVID-19-associated hospitalizations and deaths prevented among vaccinated adults in the US. The results indicate that the COVID-19 vaccination program in the US has successfully reduced the burden of morbidity and mortality by directly protecting vaccinated individuals.

JAMA NETWORK OPEN (2022)

添加到收藏夹

Article Immunology

SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis

Cumali Efe et al.

Summary: This study evaluated the outcomes of COVID-19 in patients with autoimmune hepatitis (AIH) who received COVID-19 vaccines. The results showed that vaccinated patients had lower rates of hospitalization, need for oxygen supplementation, and mortality compared to unvaccinated patients. Receiving at least one dose of the SARS-CoV-2 vaccine was associated with a significantly lower risk of worse COVID-19 severity and mortality.

JOURNAL OF AUTOIMMUNITY (2022)

添加到收藏夹

Article Immunology

Association between immunosuppressants and poor antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases

Hu Li et al.

Summary: This study investigated the antibody and B cell responses to inactivated SARS-CoV-2 vaccination in patients with autoimmune liver disease (AILD). The results showed that AILD patients had significantly lower titers of antibodies and lower seropositivity rates of neutralizing antibodies compared to healthy controls. Immunosuppressive therapy was identified as an independent risk factor for poor antibody responses in AILD patients. However, there was no significant difference in SARS-CoV-2-specific memory B cell responses between the AILD and healthy control groups.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Review Immunology

Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness

SubbaRao Tulimilli et al.

Summary: The incidence and death toll of SARS-CoV-2 infection vary and depend on factors such as viral load, immune status, age, gender, vaccination status, and comorbidities. The RNA genome of SARS-CoV-2 has mutated, resulting in several variants, including the Omicron variant that has attracted attention. These variants pose a significant threat to public health due to their altered virulence, transmissibility, and ability to evade the immune response. Further research is needed to determine the effectiveness of vaccines against these variants.

VACCINES (2022)

添加到收藏夹

Review Immunology

Global Excess Mortality during COVID-19 Pandemic: A Systematic Review and Meta-Analysis

Weijing Shang et al.

Summary: This study assessed the global excess mortality during the COVID-19 pandemic. The results showed that the global excess mortality rate was 104.84 deaths per 100,000, and the reported all-cause deaths were higher than expected deaths. South America, developing and middle-income countries, male populations, and individuals aged >= 60 years had a heavier burden of excess mortality.

VACCINES (2022)

添加到收藏夹

Article Rheumatology

Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies

Laura Boekel et al.

Summary: This study found that older patients with autoimmune diseases on specific immunosuppressive drugs may have delayed antibody development after the first COVID-19 vaccination. However, second or repeated exposure to SARS-CoV-2, either through infection or vaccination, can improve humoral immunity in these patients. Delaying the second dose of COVID-19 vaccines in patients receiving immunosuppressive drugs should be avoided, and future studies including younger patients are needed to confirm the generalizability of the results.

LANCET RHEUMATOLOGY (2021)

添加到收藏夹

Letter Immunology

Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection

Tiandan Xiang et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients

Markus Cornberg et al.

Summary: According to a recent estimate by the World Health Organization, the SARS-CoV-2 pandemic has affected nearly 100 million people globally, with patients with chronic liver diseases (CLD) at higher risk of infections. Vaccination against various pathogens, including SARS-CoV-2, is important for these patients, although impaired immune responses may affect the efficacy of immunization. The safety, immunogenicity, and efficacy of SARS-CoV-2 vaccines in patients with CLD, cirrhosis, hepatobiliary cancer, and liver transplant recipients still require further study.

JOURNAL OF HEPATOLOGY (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

Under-reporting of deaths limits our understanding of true burden of covid-19

Charles Whittaker et al.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Article Immunology

Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting

Ziwei Li et al.

Frontiers in Immunology (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study

Jitao Wang et al.

Summary: The study demonstrates that COVID-19 vaccination is safe and immunogenic in patients with non-alcoholic fatty liver disease (NAFLD). Most adverse reactions post-vaccination are mild and transient.

JOURNAL OF HEPATOLOGY (2021)

添加到收藏夹

Article Rheumatology

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study

Victoria Furer et al.

Summary: Vaccination with mRNA BNT162b2 vaccine showed reduced immunogenicity in patients with AIIRD compared to the general population, with risk factors including older age and treatment with glucocorticoids, rituximab, mycophenolate mofetil (MMF), and abatacept. However, most patients maintained stable disease activity post-vaccination.

ANNALS OF THE RHEUMATIC DISEASES (2021)

添加到收藏夹

Article Medicine, General & Internal

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

Mine Durusu Tanriover et al.

Summary: The study presented the interim efficacy and safety results of the CoronaVac vaccine in a phase 3 clinical trial in Turkey, demonstrating high efficacy against PCR-confirmed symptomatic COVID-19 with good safety and tolerability profile. Results showed significant differences in the frequency of any adverse events between the vaccine and placebo groups, indicating excellent protective effects of the vaccine.

LANCET (2021)

添加到收藏夹

Article Medicine, General & Internal

Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation

Saleh A. Alqahtani et al.

ANNALS OF SAUDI MEDICINE (2020)

添加到收藏夹

Review Gastroenterology & Hepatology

Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic

Tobias Boettler et al.

JHEP REPORTS (2020)

添加到收藏夹

Review Hematology

The role of plasma exchange in the management of autoimmune disorders

Elisabetta Zanatta et al.

BRITISH JOURNAL OF HAEMATOLOGY (2019)

添加到收藏夹

Article Immunology

Effect of statin use on the risk of medically attended acute respiratory illness among influenza vaccinated elderly

Hsien-Tsung Chiu et al.

VACCINE (2018)

添加到收藏夹

Review Immunology

Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review

Andreas Kronbichler et al.

AUTOIMMUNITY REVIEWS (2016)

添加到收藏夹

Article Peripheral Vascular Disease

Immunoadsorption for connective tissue disease

B. Hohenstein et al.

ATHEROSCLEROSIS SUPPLEMENTS (2013)

添加到收藏夹

Article Hematology

Artificial liver support system in China: A review over the last 30 years

LJ Li et al.

THERAPEUTIC APHERESIS AND DIALYSIS (2006)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.